Author: Vikas Kumar
12 January 2023
The non-invasive aesthetic treatment marketis expected to witness a CAGR of around 14% during the forecast period. Over invasive therapy, non-invasive aesthetics has advantages including reduced pain, quick results, and lower cost. Non-invasive aesthetic therapy helps to prevent the indications of aging but does not provide permanent benefits; it only temporarily improves facial appearance. The non-invasive aesthetic treatments are being increasingly used for skin and hair treatments, which include different procedures such as facial & body contouring, facial & skin rejuvenation, hair removal, breast enhancement, scar treatment, reconstructive surgery, and pigmented lesions removal.
Moreover, technological advancements and the rising popularity of non-invasive or minimally invasive aesthetic procedures are propelling the aesthetic devices market during the forecast period. For instance, in 2020, according to the International Society of Aesthetic Plastic Surgery (ISAPS) global survey, there were 10,129,528 surgical procedures and 14,400,347 nonsurgical procedures performed worldwide.
For a detailed analysis of the Global Non-Invasive Aesthetic Treatment Market browse through – https://univdatos.com/report/non-invasive-aesthetic-treatment-market/
Based on procedure, the market is segmented into injectables, skin rejuvenation, and others. Among these, the injectables category is to witness a higher CAGR during the forecast period. This is mainly due to the various advantages offered by injectables such as smooth skin, cure wrinkles & facial lines, and boosting collagen production in the skin. These essential skin advantages have increased the demand for injectables around the world and contributed to the growth of the segment.
On the basis of end-use, the market is categorized into hospital/surgery center, medspa, traditional spa, and HCP-owned clinics. Among these, the hospital/surgery center to hold a significant share of the market in 2020. This is mainly due to many aesthetic procedures, particularly breast procedures, blepharoplasty, rhinoplasty, and other minimally invasive procedures, which are performed in hospitals. For instance, in 2020, according to the International Society of Aesthetic Plastic Surgery (ISAPS) global survey, there were 852,554 rhinoplasty procedures performed worldwide.
Request for a sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=32273
For a better understanding of the market adoption of the non-invasive aesthetic treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the availability of surgeons & skilled professionals the increasing aesthetic or non-aesthetic procedures, high income, advanced healthcare infrastructure, and adoption of aesthetic devices. These factors are further propelling the regional growth rate during the forecast period. Furthermore, according to the American Society of Plastic Surgeons (ASPS), around $16.7 billion was spent on cosmetic procedures in the U.S.
Some of the major players operating in the market include Hologic Inc., GALDERMA, Alma Lasers, Johnson & Johnson Private Limited, Merz Pharma, Lumenis Be Ltd., Cutera, REVANCE AESTHETICS, Bausch Health Companies Inc., and AbbVie Inc.
Global Non-Invasive Aesthetic Treatment Market Segmentation
Market Insight, by Procedure
Market Insight, by Drive Type
Market Insight, by Region
Top Company Profiles
Get a call back
